Guidance ledger · Q4 FY26

Deepak Nitrite Ltd DEEPAKNTR

4 revisions on record · 3 lowered · 0 raised — the strikethrough is what management used to say

directional guidance only · shifted across quarters

Holding view → · latest concall · The pulse

↓ lowered MIBK/MIBC commissioning timeline Q1 FY26 → Q4 FY26

~~H2FY26 (Q1FY26)~~ → tail end of Q1FY27 or early Q2FY27

“tail end of Q1 or the early part of Q2 is when we will be looking at commissioning of the asset”

↓ lowered Nitric acid utilization Q1 FY26 → Q4 FY26

~~100%+ from Q3FY26 onwards (Q1FY26)~~ → 45% in Q4FY26 due to technical issues

“during this quarter under review, we were roughly at about 45% of”

→ narrowed AI segment EBIT margin trajectory Q1 FY26 → Q4 FY26

~~double-digit EBIT margins maybe sometime next year (Q1FY26)~~ → stronger margin profile in FY27 vs FY26; Q1FY27 better than Q4FY26

“a stronger margin profile, even for the standalone business, compared with FY2 6”

↓ lowered Polycarbonate commissioning Q2 FY26 → Q4 FY26

~~by March 2028 (Q2FY26)~~ → by June 2028

“are expecting it to be commissioned by June 2028.”

Method. Revisions come from management's own stated numbers, compared quarter over quarter across the covered concalls; each carries the verbatim quote. “No revisions” can also mean guidance too vague to pin down — see the posture chip above. Not investment advice.